Y-type polyethylene glycol modified GCSF and preparation method and use thereof

Details for Australian Patent Application No. 2007363326 (hide)

Owner Biosteed Gene Expression Tech. Co., Ltd.

Inventors Cai, Huili; Zhong, Liping; Chen, Ping; He, Yan; Zheng, Jianhua; Wang, Shiyuan; Sun, Li; Huang, Shuying; Yang, Meihua; Deng, Hongyuan

Agent Davies Collison Cave

Pub. Number AU-A-2007363326

PCT Pub. Number WO2009/086656

Filing date 29 December 2007

Wipo publication date 16 July 2009

International Classifications

C07K 17/08 (2006.01) Carrier-bound or immobilised peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 1/02 (2006.01) General processes for the preparation of peptides

C07K 14/535 (2006.01) Peptides having more than 20 amino acids

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/086656 Priority application(s): WO2009/086656

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007420983

2007363281-Hybrid nanocomposite